메뉴 건너 뛰기
SinilPharm

Financial Information

BalanceSheet

Financial items 2016, 12 2015, 12 2014, 12
Price Composition Growth Price Composition Growth Price Composition Growth
TOTAL CURRENT ASSETS 53,787 54.9 ▲17.4 45,830 52.5 ▲1.3 45,221 56.6 ▲25.1
TOTAL NON-CURRENT ASSETS 44,266 45.1 ▲6.8 41,434 47.5 ▲19.5 34,685 43.4 ▲.6
TOTAL ASSETS 98,053 100 ▲12.4 87,264 100 ▲9.2 79,906 100 ▲13.2
TOTAL CURRENT LIABILITIES 7,378 7.5 ▲5.2 7,016 8 ▼-14.5 8,202 10.3 ▲1.3
TOTAL NON-CURRENT LIABILITIES 3,485 3.6 ▲68 2,074 2.4 ▲143.2 853 1.1 ▲153.7
TOTAL LIABILITIES 10,863 11.1 ▲19.5 9,091 10.4 ▲.4 9,055 11.3 ▲7.3
Capital stocks 3,950 4 0 3,950 4.5 0 3,950 4.9 0
Capital surplus 2,671 2.7 0 2,671 3.1 0 2,671 3.3 0
Retained earnings 80,640 82.2 ▲12.6 71,623 82.1 ▲11.3 64,371 80.6 ▲15.6
TOTAL STOCKHOLDERS' EQUITY 87,190 88.9 ▲11.5 78,173 89.6 ▲10.3 70,851 88.7 ▲14

Income Statement

Financial items 2016, 12 2015, 12 2014, 12
Price Composition Growth Price Composition Growth Price Composition Growth
SALES(NET) 50,212 100 ▲12.3 44,703 100 ▼-7.2 48,160 100 ▲8.7
GROSS PROFIT 23,847 47.5 ▲8.1 22,055 49.3 ▼-9.2 24,294 50.4 ▲9.9
OPERATING INCOME 11,348 22.6 ▲7.9 10,512 23.5 ▼-14.3 12,264 25.5 ▲29
NON-OPERATING INCOME 695 1.4 ▼-7.4 750 1.7 ▼-35.9 1,170 2.4 ▲89.1
NON-OPERATING EXPENSES 306 .6 ▼-57.3 717 1.6 ▼-34.8 1,099 2.3 ▼-12.8
NET INCOME 10,038 20 ▲14.5 8,764 19.6 ▼-13.9 10,179 21.1 ▲39

Cash Flow Statement

Financial items 2016년 12월 2015년 12월 2014년 12월
Composition On changes Composition On changes Composition On changes
Cash flows from operating activities 4,235 ▼-55.7 9,564 ▲2.5 9,329 ▼-23.9
Cash flows from investing activities -4,720 ▲53.8 -10,217 ▼-25.8 -8,120 ▲29.1
CF from financing act. -1,049 ▼-82.7 -574 ▼-49.4 -384 ▲28.9
Increases(Decreases) in cash -1,534 ▼-25.1 -1,227 ▼-248.9 824 ▲205.6
Cash at the beginning of the period 2,071 ▼-37.2 3,298 ▲33.3 2,474 ▲12.2
Cash at the end of the period 538 ▼-74 2,071 ▼-37.2 3,298 ▲33.3